BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20710017)

  • 1. The utility of the post-concussive symptom questionnaire.
    Van Dyke SA; Axelrod BN; Schutte C
    Arch Clin Neuropsychol; 2010 Nov; 25(7):634-9. PubMed ID: 20710017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing effort: differentiating performance and symptom validity.
    Van Dyke SA; Millis SR; Axelrod BN; Hanks RA
    Clin Neuropsychol; 2013; 27(8):1234-46. PubMed ID: 24028487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of MMPI-2 validity scale scores of personal injury litigants and disability claimants.
    Tsushima WT; Geling O; Fabrigas J
    Clin Neuropsychol; 2011 Nov; 25(8):1403-14. PubMed ID: 22003896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the response bias scale (RBS) and other MMPI-2 validity scales in predicting TOMM performance.
    Whitney KA; Davis JJ; Shepard PH; Herman SM
    Arch Clin Neuropsychol; 2008; 23(7-8):777-86. PubMed ID: 18930375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting negative response bias with the Fake Bad Scale, Response Bias Scale, and Henry-Heilbronner Index of the Minnesota Multiphasic Personality Inventory-2.
    Dionysus KE; Denney RL; Halfaker DA
    Arch Clin Neuropsychol; 2011 Mar; 26(2):81-8. PubMed ID: 21148668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a Response Bias Scale (RBS) for the MMPI-2.
    Gervais RO; Ben-Porath YS; Wygant DB; Green P
    Assessment; 2007 Jun; 14(2):196-208. PubMed ID: 17504891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validating the usefulness of the NSI validity-10 with the MMPI-2-RF.
    Gradwohl BD; Mangum RW; Tolle KA; Pangilinan PH; Bieliauskas LA; Spencer RJ
    Int J Neurosci; 2020 Sep; 130(9):926-932. PubMed ID: 31928283
    [No Abstract]   [Full Text] [Related]  

  • 8. Incremental validity of the MMPI-2-RF over-reporting scales and RBS in assessing the veracity of memory complaints.
    Gervais RO; Ben-Porath YS; Wygant DB; Sellbom M
    Arch Clin Neuropsychol; 2010 Jun; 25(4):274-84. PubMed ID: 20335183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity of the Response Bias Scale (RBS) and MMPI-2 validity scales to memory complaints.
    Gervais RO; Ben-Porath YS; Wygant DB; Green P
    Clin Neuropsychol; 2008 Dec; 22(6):1061-79. PubMed ID: 18609315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of selected MMPI-2 and MMPI-2-RF validity scales in assessing effort on cognitive tests in a military sample.
    Jones A; Ingram MV
    Clin Neuropsychol; 2011 Oct; 25(7):1207-27. PubMed ID: 21902565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of response bias and noncredible performance in adult attention-deficit/hyperactivity disorder.
    Young JC; Gross AM
    Arch Clin Neuropsychol; 2011 Apr; 26(3):165-75. PubMed ID: 21441258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scores on the MMPI-2-RF scales as a function of increasing levels of failure on cognitive symptom validity tests in a military sample.
    Jones A; Ingram MV; Ben-Porath YS
    Clin Neuropsychol; 2012; 26(5):790-815. PubMed ID: 22709365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A known-groups evaluation of the response bias scale in a neuropsychological setting.
    Sullivan KA; Elliott CD; Lange RT; Anderson DS
    Appl Neuropsychol Adult; 2013; 20(1):20-32. PubMed ID: 23373681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Minnesota Multiphasic Personality Inventory-2-RF in Treatment-Seeking Veterans with History of Mild Traumatic Brain Injury.
    Jurick SM; Crocker LD; Keller AV; Hoffman SN; Bomyea J; Jacobson MW; Jak AJ
    Arch Clin Neuropsychol; 2018 May; 34(3):366-380. PubMed ID: 29850866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the MMPI-2 Response Bias Scale and Henry-Heilbronner Index in a U.S. veteran population.
    Young JC; Kearns LA; Roper BL
    Arch Clin Neuropsychol; 2011 Apr; 26(3):194-204. PubMed ID: 21459900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minnesota Multiphasic Personality Inventory-2 revised form Symptom Validity Scale-Revised (MMPI-2-RF FBS-r; also known as Fake Bad Scale): psychometric characteristics in a nonlitigation neuropsychological setting.
    Gass CS; Odland AP
    J Clin Exp Neuropsychol; 2012; 34(6):561-70. PubMed ID: 22384793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MMPI-2 Symptom Validity Scale (FBS) not influenced by medical impairment: a large sleep center investigation.
    Greiffenstein MF
    Assessment; 2010 Jun; 17(2):269-77. PubMed ID: 20124428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response validity in forensic neuropsychology: exploratory factor analytic evidence of distinct cognitive and psychological constructs.
    Nelson NW; Sweet JJ; Berry DT; Bryant FB; Granacher RP
    J Int Neuropsychol Soc; 2007 May; 13(3):440-9. PubMed ID: 17445293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of the MMPI-2 malingering discriminant function index in the detection of malingering: a study of criminal defendants.
    Toomey JA; Kucharski LT; Duncan S
    Assessment; 2009 Mar; 16(1):115-21. PubMed ID: 18607009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between Symptom Validity Test failure and scores on the MMPI-2-RF validity and substantive scales.
    Gervais RO; Wygant DB; Sellbom M; Ben-Porath YS
    J Pers Assess; 2011; 93(5):508-17. PubMed ID: 21859291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.